NCT07505069 2026-04-01
Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors
Nanolattix Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Recruiting
Clinical Trials
14 trialsNCT07504445 2026-03-31
Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors
Peking University Shenzhen Hospital
Phase EARLY_PHASE1 Recruiting
NCT07487597 2026-03-23
Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors
TCRCure Biopharma Ltd.
Phase EARLY_PHASE1 Recruiting
NCT07274813 2026-03-03
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase EARLY_PHASE1 Recruiting
NCT05645523 2026-02-25
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
St. Jude Children's Research Hospital
Phase EARLY_PHASE1 Recruiting
NCT07420010 2026-02-19
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT07412665 2026-02-17
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
Beijing Geekgene Technology Co., LTD
Phase EARLY_PHASE1 Not yet recruiting
NCT07414316 2026-02-17
A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
Beijing Geekgene Technology Co., LTD
Phase EARLY_PHASE1 Recruiting
NCT07220447 2026-02-12
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
City of Hope Medical Center
Phase EARLY_PHASE1 Recruiting
NCT06824155 2026-02-11
RAD202
Radiopharm Theranostics, Ltd
Phase EARLY_PHASE1 Recruiting
NCT03813615 2026-02-04
Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT07327632 2026-02-04
This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors
Innovent Biologics Technology Limited (Shanghai R&D Center)
Phase EARLY_PHASE1 Recruiting
NCT04733027 2026-01-22
Clever Peptide
Institut Curie
Phase EARLY_PHASE1 Active not recruiting
NCT07108140 2026-01-22
Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
TCRCure Biopharma Ltd.
Phase EARLY_PHASE1 Terminated